Companies Cryptocurrencies
Arbutus Biopharma Corp
Arbutus Biopharma Corp
Exchange: Nasdaq Global Select
IPO Date: 13/11/2010
CEO: Mr. William Collier
Biotechnology Healthcare 🔗
  • ABUS
    symbol
  • 4.62
    price
  • 458124736
    market cap
  • 0
    changes
If you bought

shares of Arbutus Biopharma Corp (ABUS) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, British Columbia and currently employs 80 full-time employees. The firm is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The firm develops a portfolio of drug candidates with multiple mechanisms of action that results in a combination therapy to cure HBV. In addition to its HBV pipeline, the Company actively licenses its Lipid Nanoparticle (LNP) technology to its industry partners. This technology represents a delivery technology in RNA interference (RNAi) therapeutic development, which has enabled several clinical trials and has been administered to hundreds of human subjects.

Address: 701 Veterans Circle Warminster PENNSYLVANIA 18974

Stay updated.